Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
Work
Year: 2016
Type: article
Abstract: Treatment with an aromatase inhibitor for 5 years as up-front monotherapy or after tamoxifen therapy is the treatment of choice for hormone-receptor-positive early breast cancer in postmenopausal wome... more
Source: New England Journal of Medicine
Authors Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, Nicholas J. Robert, Hyman B. Muss +15 more
Institutions Massachusetts General Hospital, Harvard University, Mayo Clinic in Arizona, Sunnybrook Health Science Centre, The US Oncology Network +18 more
Cites: 21
Cited by: 585
Related to: 10
FWCI: 53.66
Citation percentile (by year/subfield): 100
Subfield: Genetics
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze